1. Home
  2. BYD vs CORT Comparison

BYD vs CORT Comparison

Compare BYD & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boyd Gaming Corporation

BYD

Boyd Gaming Corporation

HOLD

Current Price

$73.26

Market Cap

5.7B

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$112.07

Market Cap

9.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BYD
CORT
Founded
1973
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
9.7B
IPO Year
1996
2001

Fundamental Metrics

Financial Performance
Metric
BYD
CORT
Price
$73.26
$112.07
Analyst Decision
Hold
Buy
Analyst Count
11
5
Target Price
$90.82
$96.50
AVG Volume (30 Days)
827.3K
759.6K
Earning Date
04-23-2026
04-30-2026
Dividend Yield
0.93%
N/A
EPS Growth
264.46
N/A
EPS
3.12
0.09
Revenue
$2,626,730,000.00
$761,407,000.00
Revenue This Year
$1.71
$26.08
Revenue Next Year
$2.74
$26.98
P/E Ratio
$23.80
$1,276.22
Revenue Growth
9.41
12.79
52 Week Low
$74.23
$28.66
52 Week High
$91.41
$126.38

Technical Indicators

Market Signals
Indicator
BYD
CORT
Relative Strength Index (RSI) 26.41 47.72
Support Level N/A $108.25
Resistance Level $90.37 $124.30
Average True Range (ATR) 1.59 4.83
MACD -0.14 -0.95
Stochastic Oscillator 1.95 28.50

Price Performance

Historical Comparison
BYD
CORT

About BYD Boyd Gaming Corporation

Boyd Gaming Corp is a multi-jurisdictional gaming company. The company operates wholly-owned gaming entertainment properties (casino space, slot machines, table games, and hotel rooms) in Nevada, Illinois, Indiana, Iowa, Kansas, Louisiana, Mississippi, Missouri, Ohio, and Pennsylvania. Geographical regions separate its business segments: Las Vegas Locals, Downtown Las Vegas, Midwest and South, and Online. The Midwest and South hold the key number of entertainment properties and generate the majority of the company's revenue.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: